<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0100">
 <label>20</label>
 <element-citation publication-type="journal" id="h0100">
  <person-group person-group-type="author">
   <name>
    <surname>Agnandji</surname>
    <given-names>S.T.</given-names>
   </name>
   <name>
    <surname>Huttner</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Zinser</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Njuguna</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Dahlke</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Fernandes</surname>
    <given-names>J.F.</given-names>
   </name>
  </person-group>
  <article-title>Phase 1 trials of rVSV Ebola vaccine in Africa and Europe</article-title>
  <source>N Engl J Med</source>
  <volume>374</volume>
  <issue>17</issue>
  <year>2016</year>
  <fpage>1647</fpage>
  <lpage>1660</lpage>
  <pub-id pub-id-type="pmid">25830326</pub-id>
 </element-citation>
</ref>
